In silico identification of MicroRNAs targeting the key nucleator of stress granules, G3BP: Promising therapeutics for SARS-CoV-2 infection

Stress granules (SGs) are non-membrane ribonucleoprotein condensates formed in response to environmental stress conditions via liquid–liquid phase separation (LLPS). SGs are involved in the pathogenesis of aging and aging-associated diseases, cancers, viral infection, and several other diseases. GTP...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bjad K. Almutairy, Abdullah Alshetaili, Md. Khalid Anwer, Nemat Ali
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/5af723e4b291473a996966e99bdff6ac
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5af723e4b291473a996966e99bdff6ac
record_format dspace
spelling oai:doaj.org-article:5af723e4b291473a996966e99bdff6ac2021-11-20T04:57:06ZIn silico identification of MicroRNAs targeting the key nucleator of stress granules, G3BP: Promising therapeutics for SARS-CoV-2 infection1319-562X10.1016/j.sjbs.2021.08.056https://doaj.org/article/5af723e4b291473a996966e99bdff6ac2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S1319562X21007336https://doaj.org/toc/1319-562XStress granules (SGs) are non-membrane ribonucleoprotein condensates formed in response to environmental stress conditions via liquid–liquid phase separation (LLPS). SGs are involved in the pathogenesis of aging and aging-associated diseases, cancers, viral infection, and several other diseases. GTPase-activating protein (SH3 domain)-binding protein 1 and 2 (G3BP1/2) is a key component and commonly used marker of SGs. Recent studies have shown that SARS-CoV-2 nucleocapsid protein via sequestration of G3BPs inhibits SGs formation in the host cells. In this study, we have identified putative miRNAs targeting G3BP in search of modulators of the G3BP expression. These miRNAs could be considered as new therapeutic targets against COVID-19 infection via the regulation of SG assembly and dynamics.Bjad K. AlmutairyAbdullah AlshetailiMd. Khalid AnwerNemat AliElsevierarticleCOVID-19SARS-CoV-2NucleocapsidStress granuleG3BPmicroRNABiology (General)QH301-705.5ENSaudi Journal of Biological Sciences, Vol 28, Iss 12, Pp 7499-7504 (2021)
institution DOAJ
collection DOAJ
language EN
topic COVID-19
SARS-CoV-2
Nucleocapsid
Stress granule
G3BP
microRNA
Biology (General)
QH301-705.5
spellingShingle COVID-19
SARS-CoV-2
Nucleocapsid
Stress granule
G3BP
microRNA
Biology (General)
QH301-705.5
Bjad K. Almutairy
Abdullah Alshetaili
Md. Khalid Anwer
Nemat Ali
In silico identification of MicroRNAs targeting the key nucleator of stress granules, G3BP: Promising therapeutics for SARS-CoV-2 infection
description Stress granules (SGs) are non-membrane ribonucleoprotein condensates formed in response to environmental stress conditions via liquid–liquid phase separation (LLPS). SGs are involved in the pathogenesis of aging and aging-associated diseases, cancers, viral infection, and several other diseases. GTPase-activating protein (SH3 domain)-binding protein 1 and 2 (G3BP1/2) is a key component and commonly used marker of SGs. Recent studies have shown that SARS-CoV-2 nucleocapsid protein via sequestration of G3BPs inhibits SGs formation in the host cells. In this study, we have identified putative miRNAs targeting G3BP in search of modulators of the G3BP expression. These miRNAs could be considered as new therapeutic targets against COVID-19 infection via the regulation of SG assembly and dynamics.
format article
author Bjad K. Almutairy
Abdullah Alshetaili
Md. Khalid Anwer
Nemat Ali
author_facet Bjad K. Almutairy
Abdullah Alshetaili
Md. Khalid Anwer
Nemat Ali
author_sort Bjad K. Almutairy
title In silico identification of MicroRNAs targeting the key nucleator of stress granules, G3BP: Promising therapeutics for SARS-CoV-2 infection
title_short In silico identification of MicroRNAs targeting the key nucleator of stress granules, G3BP: Promising therapeutics for SARS-CoV-2 infection
title_full In silico identification of MicroRNAs targeting the key nucleator of stress granules, G3BP: Promising therapeutics for SARS-CoV-2 infection
title_fullStr In silico identification of MicroRNAs targeting the key nucleator of stress granules, G3BP: Promising therapeutics for SARS-CoV-2 infection
title_full_unstemmed In silico identification of MicroRNAs targeting the key nucleator of stress granules, G3BP: Promising therapeutics for SARS-CoV-2 infection
title_sort in silico identification of micrornas targeting the key nucleator of stress granules, g3bp: promising therapeutics for sars-cov-2 infection
publisher Elsevier
publishDate 2021
url https://doaj.org/article/5af723e4b291473a996966e99bdff6ac
work_keys_str_mv AT bjadkalmutairy insilicoidentificationofmicrornastargetingthekeynucleatorofstressgranulesg3bppromisingtherapeuticsforsarscov2infection
AT abdullahalshetaili insilicoidentificationofmicrornastargetingthekeynucleatorofstressgranulesg3bppromisingtherapeuticsforsarscov2infection
AT mdkhalidanwer insilicoidentificationofmicrornastargetingthekeynucleatorofstressgranulesg3bppromisingtherapeuticsforsarscov2infection
AT nematali insilicoidentificationofmicrornastargetingthekeynucleatorofstressgranulesg3bppromisingtherapeuticsforsarscov2infection
_version_ 1718419716424335360